Quitting patterns and predictors of success among participants in a tobacco cessation program provided by pharmacists in New Mexico

Journal of Managed Care Pharmacy

Volumn 20, Issue 6, 2014, Pages 579-587

  Shen, Xian ^a   Bachyrycz, Amy ^b,c   Anderson, Joe R ^d   Tinker, Dale ^e,f   Raisch, Dennis W ^d  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

^c Walgreens Patient Care Center   (United States)

^d UNIVERSITY OF NEW MEXICO   (United States)

^e New Mexico Pharmaceutical Care Foundation   (United States)

^f New Mexico Pharmacists Association   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VARENICLINE;

ADULT; AGED; ARTICLE; FEMALE; HEALTH CARE PERSONNEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MANAGED CARE ORGANIZATION; NICOTINE REPLACEMENT THERAPY; OUTCOME ASSESSMENT; PHARMACIST; PREVALENCE; SMOKING CESSATION; SMOKING CESSATION PROGRAM; TOBACCO DEPENDENCE; UNITED STATES; ADVERSE OUTCOME; FOLLOW UP; LOGISTIC REGRESSION ANALYSIS; NEW MEXICO; PHARMACEUTICAL CARE; ADOLESCENT; HEALTH CARE DELIVERY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT COMPLIANCE; PHARMACY; PROCEDURES; PROFESSIONAL STANDARD; PROGRAM EVALUATION; RECURRENT DISEASE; SMOKING; STATISTICAL MODEL; TIME; TOBACCO USE DISORDER; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; COMMUNITY PHARMACY SERVICES; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEW MEXICO; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATIENT COMPLIANCE; PHARMACISTS; PROFESSIONAL ROLE; PROGRAM EVALUATION; RECURRENCE; SMOKING; SMOKING CESSATION; TIME FACTORS; TOBACCO USE DISORDER; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84901199398     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2014.20.6.579     Document Type: Article

References (32)

1. DiClemente CC, Prochaska JO. Self-change and therapy change of smoking behavior: a comparison of processes of change in cessation and maintenance. Addict Behav. 1982;7(2):133-42.
2. Prochaska JO, DiClemente CC. Stages and processes of self-change of smoking: toward an integrative model of change. Journal Consult Clin Psychol. 1983;51(3):390-95.
3. Cahill K, Lancaster T, Green N. Stage-based interventions for smoking cessation. Cochrane Database Syst Rev. 2010(11):CD004492.
4. Pisinger C, Aadahl M, Toft U, Jøgensen T. Motives to quit smoking and reasons to relapse differ by socioeconomic status. Prev Med. 2011;52(1):48-52.
5. Yang T, Fisher KJ, Li F, Danaher BG. Attitudes to smoking cessation and triggers to relapse among Chinese male smokers. BMC Public Health. 2006;6:65.
6. Dent LA, Scott JG, Lewis E. Pharmacist-managed tobacco cessation program in Veterans Health Administration community-based outpatient clinic. J Am Pharm Assoc (2003). 2004;44(6):700-14.
7. Roth MT, Westman EC. Use of bupropion SR in a pharmacist-managed outpatient smoking-cessation program. Pharmacotherapy. 2001;21(5):636-41.
8. Zillich AJ, Ryan M, Adams A, Yeager B, Farris K. Effectiveness of a pharmacist-based smoking-cessation program and its impact on quality of life. Pharmacotherapy. 2002;22(6):759-65.
9. Kennedy DT, Giles JT, Chang ZG, Small RE, Edwards JH. Results of a smoking cessation clinic in community pharmacy practice. J Am Pharm Assoc (Wash). 2002;42(1):51-56.
10. Fiore MC, Jaé CR, Baker TB, et al. Treating tobacco use and dependence: 2008 update. Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service. May 2008. Available at: http://bphc.hrsa.gov/buckets/treatingtobacco.pdf. Accessed April 30, 2014.
11. Unrod M, Smith M, Spring B, DePue J, Redd W, Winkel G. Randomized controlled trial of a computer-based, tailored intervention to increase smoking cessation counseling by primary care physicians. J Gen Intern Med. 2007;22(4):478-84.
12. Wewers ME, Ferketich AK, Harness J, Paskett ED. Effectiveness of a nurse-managed, lay-led tobacco cessation intervention among Ohio Appalachian women. Cancer Epidemiol Biomarkers Prev. 2009;18(12):3451-58.
13. Liberman JN, Lichtenfeld MJ, Galaznik A, et al. Adherence to varenicline and associated smoking cessation in a community-based patient setting. J Manag Care Pharm. 2013;19(2):125-31. Available at: http://www.amcp.org/ WorkArea/DownloadAsset.aspx?id=16219.
14. Gonzales D, Jorenby DE, Brandon TH, Arteaga C, Lee TC. Immediate versus delayed quitting and rates of relapse among smokers treated successfully with varenicline, bupropion SR or placebo. Addiction. 2010;105(11):2002-13.
15. Hajek P, Tonnesen P, Arteaga C, Russ C, Tonstad S. Varenicline in prevention of relapse to smoking: effect of quit pattern on response to extended treatment. Addiction. 2009;104(9):1597-602.
16. University of California San Francisco. Rx for Change. Clinician-assisted tobacco cessation. Available at: http://rxforchange.ucsf.edu/. Accessed April 24, 2014.
17. Williams DM. Preparing pharmacy students and pharmacists to provide tobacco cessation counselling. Drug Alcohol Rev. 2009;28(5):533-40.
18. Glynn TJ, Manley MW. How to help your patients stop smoking: a National Cancer Institute manual for physicians. NIH Publication No. 89-3064. Bethesda, MD: National Institutes of Health; 1997.
19. SAS Institute. Type III tests. SAS OnlineDoc V8. Carey, NC. Available at: http://v8doc.sas.com/sashtml/insight/chap39/sect25.htm. Accessed April 24, 2014.
20. Healthy People 2020. 2020 topics and objectives: tobacco use. Healthy People.gov. August 2013. Available at: http://www.healthypeople.gov/2020/topicsobjectives2020/ objectiveslist.aspx?topicId=41. Accessed April 24, 2014.
21. World Health Organization. World health statistics 2008. Available at: http://www.who.int/gho/publications/world_health_statistics/EN_WHS08_ Full.pdf. Accessed April 24, 2014.
22. Bauld L, Boyd KA, Briggs AH, et al. One-year outcomes and a costeffectiveness analysis for smokers accessing group-based and pharmacy-led cessation services. Nicotine Tob Res. 2011;13(2):135-45.
23. Appleby J, Devlin N, Parkin D. NICE's cost effectiveness threshold. BMJ. 2007;335(7616):358-59.
24. Lancaster T, Dobbie W, Vos K, Yudkin P, Murphy M, Fowler G. Randomized trial of nurse-assisted strategies for smoking cessation in primary care. Brit J Gen Pract. 1999;49(440):191-94.
25. Kohler CL, Schoenberger YM, Tseng TS, Ross L. Correlates of transitions in stage of change for quitting among adolescent smokers. Addict Behav. 2008;33(12):1615-18.
26. DiClemente CC, Delahanty JC, Kofeldt MG, Dixon L, Goldberg R, Lucksted A. Stage movement following a 5A's intervention in tobacco dependent individuals with serious mental illness (SMI). Addict Behav. 2011;36(3):261-64.
27. Fu SS, Burgess DJ, van Ryn M, et al. Smoking-cessation strategies for American Indians: should smoking-cessation treatment include a prescription for a complete home smoking ban? Am J Prev Med. 2010;39(6 Suppl 1):S56-S65.
28. Ji M, Hofstetter CR, Hovell M, et al. Smoking cessation patterns and predictors among adult Californians of Korean descent. Nicotine Tob Res. 2005;7(1):59-69.
29. Hyland A, Higbee C, Travers MJ, et al. Smoke-free homes and smoking cessation and relapse in a longitudinal population of adults. Nicotine Tob Res. 2009;11(6):614-18.
30. Rice VH, Templin T, Fox DH, et al. Social context variables as predictors of smoking cessation. Tob Control. 1996;5(4):280-85.
31. Lawhon D, Humfleet GL, Hall SM, Munoz RF, Reus VI. Longitudinal analysis of abstinence-specific social support and smoking cessation. Health Psychol. 2009;28(4):465-72.
32. Connor Gorber S, Schofield-Hurwitz S, Hardt J, Levasseur G, Tremblay M. The accuracy of self-reported smoking: a systematic review of the relationship between self-reported and cotinine-assessed smoking status. Nicotine Tob Res. 2009;11(1):12-24.